News
Video
Chronic Challenges in Endometrial Cancer: Recurrence and Second-Line Therapy
Author(s):
Experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD, discuss the prevalence of patients with recurrent endometrial cancer, challenges in responding to chemotherapy, and the potential for improved treatment options in the second-line setting.
EP: 1.Changing Landscape of Endometrial Cancer: Incidence and Classification
EP: 2.Optimal Workup Strategies in Advanced Endometrial Cancer
EP: 3.Factors in Frontline Treatment Decision Making for Endometrial Cancer
EP: 4.Assessing Response to First-Line Therapy in Advanced Endometrial Cancer: Clinical Factors
Now Viewing
EP: 5.Chronic Challenges in Endometrial Cancer: Recurrence and Second-Line Therapy
EP: 6.Treatment Choices for Recurrent dMMR Endometrial Cancer
EP: 7.HER2-Positive Endometrial Cancer: A Targeted Approach to Treatment
EP: 8.Treatment for Recurrent Endometrial Cancer: Chemotherapy or Lenvatinib + Pembrolizumab
EP: 9.Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizumab
EP: 10.Revolutionizing Frontline Therapy for Endometrial Cancer: Checkpoint Inhibitors and MMR Status
EP: 11.Expanding Horizons in Endometrial Cancer Treatment: Beyond Chemotherapy
EP: 12.Diversity and Access to Clinical Trials in Endometrial Cancer
Related Videos
Related Content
